Castle Biosciences's total assets for Q1 2025 were $501.71M, a decrease of -5.56% from the previous quarter. CSTL total liabilities were $61.41M for the fiscal quarter, a -18.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.